Cytotoxic drugs cause immunosuppression by killing dividing cells and have serious side-effects. Mycophenolate mofetil is a cytotoxic drug that is commonly used in patients receiving kidney transplants, as part of a combination therapy with other immunosuppressive drugs. Studies have been performed to assess whether reductions in mycophenolate mofetil dose given to transplant patients starting around 4 months post-transplant have deleterious effects on the transplanted kidney function or on episodes of graft rejection. The motivation for this type of study is:
5. The possibility that transplant patients develop an allergic reaction to the mycophenolate
Already registered? Login
Not Account? Sign up
Enter your email address to reset your password
Back to Login? Click here